Interpret
| Region | Finding |
|---|---|
| Esophagus - Upper 1/3 | Normal mucosa |
| Esophagus - Middle 1/3 | Normal mucosa |
| Esophagus - Lower 1/3 | Mucosal break <5mm |
| GE Junction | 40 cm from incisors |
| Stomach | Mucosal erythema over fundus |
| Duodenum (D1, D2) | Not visualized (patient uncooperative) |
| Parameter | Result | Reference | Interpretation |
|---|---|---|---|
| RBC Count | 5.56 H | 4.50-5.50 million/µL | Mildly elevated |
| MCV | 80.70 L | 83.00-101.00 fL | Low - Microcytosis |
| MCH | 26.30 L | 27.00-32.00 pg | Low - Hypochromia |
| Test | Result |
|---|---|
| HBsAg (Hepatitis B Surface Antigen) | Non-Reactive |
| Anti-HCV Antibody (Hepatitis C) | Non-Reactive |
| HIV Antibody | Non-Reactive |
12.5 kPa = Cirrhosis (F4)
| Investigation | Rationale |
|---|---|
| LFT / Liver Function Tests | Assess hepatocellular injury (ALT, AST, bilirubin, albumin) |
| Serum Ferritin, Iron, TIBC | Differentiate iron deficiency from thalassemia trait |
| HbA1c + Fasting Blood Sugar | Rule out diabetes as driver of NAFLD |
| Lipid Profile | Metabolic syndrome component |
| Hb Electrophoresis | If iron stores normal, to confirm/exclude thalassemia |
| H. pylori testing (UBT or stool antigen) | Explain gastric erythema; treat if positive |
| Repeat endoscopy (relook scopy) | Complete duodenal assessment (D1, D2) |
| BMI / Waist circumference | Assess metabolic risk |
Note: This interpretation is for educational/informational purposes. All clinical decisions should be made by the treating gastroenterologist (Dr. Saurabh Jindal) in the context of the full clinical history, physical examination, and additional investigations.